Gov. Polis remarks on vaccine rollout for children ages 5-11

Written by: Children's Campaign
Date Posted: November 12, 2021

Last week, with approval from the Centers for Disease Control and Prevention (CDC), Pfizer-BioNTech pediatric vaccine doses became available for children 5-11 years old. Since this endorsement, Colorado has started statewide rollout of the vaccine. 

Speaking on Nov. 8 from the steps of the capitol, Governor Jared Polis provided initial updates on pediatric vaccination efforts. As of Monday, over 11,000 children ages 5-11 have received a COVID-19 vaccine in Colorado. Approximately 480,000 Colorado children – about 8% of the state population – are now eligible to receive the vaccine. Gov. Polis shared the goal of reaching a pediatric vaccination rate of at least 50% by the end of January.

On Monday, Gov. Polis stated that one out of every 48 Coloradans currently has COVID-19 because of the ongoing presence of the highly transmissible delta variant. Increasing vaccination plays a significant role in combatting both the spread of COVID-19 and avoiding its potential and dangerous complications. Vaccination also helps prevent the development of new and more dangerous COVID-19 variants that could impact us all. There are a variety of ways to seek out a COVID-19 vaccination appointment for both you and your children. Resources to help you find a COVID-19 vaccine for your child are listed below: 

Read more about the importance of the CDC’s approval here 

Children's Campaign

Follow Children's Campaign

About Children's Campaign

The Colorado Children’s Campaign is a nonprofit, nonpartisan advocacy organization committed since 1985 to realizing every chance for every child in Colorado. We advocate for the development and implementation of data-driven public policies that improve child wellbeing in health, education and early childhood. We do this by providing Coloradans with trusted data and research on child wellbeing and organizing an extensive state-wide network of dedicated child advocates. For more information, please visit